Pharmaceutical Technology on MSN
FDA looks to simplify biosimilar development with new draft guidance
The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...
GlobalData on MSN
Eli Lilly and NVIDIA to build pharma’s “most powerful” supercomputer
Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.
AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment and de-risking projects. Digital tools bridge R&D and manufacturing, ...
AI’s true power lies in pattern recognition across messy, real-world data: Natural language processing extracts phenotypes, comorbidities, and device usability feedback from unstructured clinical ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Stacey Ma, PhD will join the company as Executive Vice President, Pharmaceutical Development and ...
WEST LAFAYETTE, Ind. — Purdue, in collaboration with Apple, plans to launch a spatial computing hub utilizing Apple Vision Pro in Fall 2025 to enable collaborative research, innovative educational ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback